يعرض 1 - 10 نتائج من 34 نتيجة بحث عن '"Sarah Blagden"', وقت الاستعلام: 1.27s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Interventions delivered in secondary or tertiary medical care settings to improve routine vaccination uptake in children and young people: a scoping review

    المؤلفون: Rachel Isba, Rhiannon Edge, Sarah Blagden, Kathryn Newell, Nareh Ghazarians, Sabrena Sulaiman, Lucy Tunn, Michael Odumala

    المصدر: BMJ Open, Vol 12, Iss 8 (2022)

    مصطلحات موضوعية: Medicine

    وصف الملف: electronic resource

    العلاقة: https://bmjopen.bmj.com/content/12/8/e061749.fullTest; https://doaj.org/toc/2044-6055Test

    الوصول الحر: https://doaj.org/article/a0753e1388c5414f9ab964a5d20c84a5Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol

    المؤلفون: Nicholas F. Brown, Stasya M. Ng, Claire Brooks, Tim Coutts, Jane Holmes, Corran Roberts, Leena Elhussein, Peter Hoskin, Tim Maughan, Sarah Blagden, Paul Mulholland

    المصدر: BMC Cancer, Vol 20, Iss 1, Pp 1-5 (2020)

    مصطلحات موضوعية: Glioblastoma, Glioma, Ipilimumab, Temozolomide, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12885-020-6624-yTest; https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/499d5079d98d4f31aaed547c17a9b1f4Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome

    المؤلفون: Pan Pantziarka, Sarah Blagden

    المصدر: Cancers, Vol 14, Iss 7, p 1621 (2022)

    مصطلحات موضوعية: Li-Fraumeni Syndrome, TP53, drug re-purposing, pre-cancer niche, cancer pre-disposition, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://www.mdpi.com/2072-6694/14/7/1621Test; https://doaj.org/toc/2072-6694Test

    الوصول الحر: https://doaj.org/article/14225ce3c88f44d2bfa09cbc949b05d2Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    The La-Related Proteins, a Family with Connections to Cancer

    المؤلفون: Chara Stavraka, Sarah Blagden

    المصدر: Biomolecules, Vol 5, Iss 4, Pp 2701-2722 (2015)

    مصطلحات موضوعية: cancer, LARP, LARP1, transcription, mRNA, translation, proliferation, RNA-binding, RBP, SS-B, Microbiology, QR1-502

    وصف الملف: electronic resource

    العلاقة: http://www.mdpi.com/2218-273X/5/4/2701Test; https://doaj.org/toc/2218-273XTest

    الوصول الحر: https://doaj.org/article/d0cce276411e43c3b27ede8b7d5556cdTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study.

    المؤلفون: Sarah Blagden, Daniel Seddon, Daniel Hungerford, Debbi Stanistreet

    المصدر: PLoS ONE, Vol 12, Iss 8, p e0181817 (2017)

    مصطلحات موضوعية: Medicine, Science

    وصف الملف: electronic resource

    العلاقة: http://europepmc.org/articles/PMC5540503?pdf=renderTest; https://doaj.org/toc/1932-6203Test

    الوصول الحر: https://doaj.org/article/9d3ba88289364c0183f030ad3bb740d9Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  6. 6
    A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

    المؤلفون: Robert Jones, Ruth Plummer, Victor Moreno, Louise Carter, Desamparados Roda, Elena Garralda, Rebecca Kristeleit, Debashis Sarker, Tobias Arkenau, Patricia Roxburgh, Harriet S. Walter, Sarah Blagden, Alan Anthoney, Barbara J. Klencke, Mark M. Kowalski, Udai Banerji

    المساهمون: Institut Català de la Salut, [Jones R] Velindre School of Medicine, Cardiff University, and Velindre University NHS Trust, Cardiff, United Kingdom. [Plummer R] Newcastle University and Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom. [Moreno V] START Madrid-Fundacion Jiménez Díaz, Fundación Jiménez Díaz University Hospital, Madrid, Spain. [Carter L] Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom. [Roda D] Biomedical Research Institute INCLIVA, Valencia, Spain. [Garralda E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Neoplasms [DISEASES], neoplasias [ENFERMEDADES], Cancer Research, Oncology, Càncer - Tractament, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings]

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b8b8b6c13c4102f92013713c378bdaTest
    https://doi.org/10.1158/1078-0432.ccr-22-2074Test


    أضف إلى المفضلة
  7. 7
    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial

    المؤلفون: Andrew R Clamp, Elizabeth C James, Iain A McNeish, Andrew Dean, Jae-Won Kim, Dearbhaile M O'Donnell, Dolores Gallardo-Rincon, Sarah Blagden, James Brenton, Tim J Perren, Sudha Sundar, Rosemary Lord, Graham Dark, Marcia Hall, Susana Banerjee, Rosalind M Glasspool, C Louise Hanna, Sarah Williams, Kate M Scatchard, Helena Nam, Sharadah Essapen, Christine Parkinson, Lucy McAvan, Ann Marie Swart, Babasola Popoola, Francesca Schiavone, Jonathan Badrock, Fuad Fananapazir, Adrian D Cook, Mahesh Parmar, Richard Kaplan, Jonathan A Ledermann

    المساهمون: Imperial College Healthcare NHS Trust- BRC Funding, Ovarian Cancer Action, National Institute for Health Research

    المصدر: The Lancet Oncology. 23:919-930

    مصطلحات موضوعية: Ovarian Neoplasms, Paclitaxel, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, 1112 Oncology and Carcinogenesis, Antineoplastic Agents, Female, Oncology & Carcinogenesis, Carcinoma, Ovarian Epithelial, Middle Aged, Fallopian Tubes, Carboplatin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458055f4aa52461a6069ccea0edee7a8Test
    https://doi.org/10.1016/s1470-2045Test(22)00283-2


    أضف إلى المفضلة
  8. 8
    A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer

    المؤلفون: Rebecca Kristeleit, Ruth Plummer, Robert Jones, Louise Carter, Sarah Blagden, Debashis Sarker, Tobias Arkenau, Thomas R. Jeffry Evans, Sarah Danson, Stefan N. Symeonides, Gareth J. Veal, Barbara J. Klencke, Mark M. Kowalski, Udai Banerji

    المصدر: British Journal of Cancer.

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9795c5e3961ea3c319c2f1e2502f3a08Test
    https://doi.org/10.1038/s41416-023-02279-xTest


    أضف إلى المفضلة
  9. 9
    Supplementary Data from First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer

    المؤلفون: Udai Banerji, James Spicer, Chris Twelves, Keith Jones, Jenny Prince, Michiyasu Inatani, Rie Shiokawa, Kohei Noguchi, Lorna Pope, Ruth Riisnaes, Karen Swales, Shaun Decordova, Alan Anthoney, David J. Pinato, Andrea Zivi, Chara Stavraka, Debra Josephs, Aurelius Olmin, Sarah Blagden

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a56fcb2c772352916f470719b5e1bfTest
    https://doi.org/10.1158/1078-0432.22455818.v1Test


    أضف إلى المفضلة
  10. 10
    Data from First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer

    المؤلفون: Udai Banerji, James Spicer, Chris Twelves, Keith Jones, Jenny Prince, Michiyasu Inatani, Rie Shiokawa, Kohei Noguchi, Lorna Pope, Ruth Riisnaes, Karen Swales, Shaun Decordova, Alan Anthoney, David J. Pinato, Andrea Zivi, Chara Stavraka, Debra Josephs, Aurelius Olmin, Sarah Blagden

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ed189fa64b7b088337fb60175edcfbdTest
    https://doi.org/10.1158/1078-0432.c.6523124Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث